{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=intramuscularly+%28IM+injection%29&page=4", "query": { "intervention": "intramuscularly (IM injection)", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 204, "total_pages": 21, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=intramuscularly+%28IM+injection%29&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=intramuscularly+%28IM+injection%29&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T16:05:38.561Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00988559", "title": "Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HPV16 Positive", "Cervical Intraepithelial Neoplasia (CIN 2/3)" ], "interventions": [ { "name": "DNA vaccination", "type": "BIOLOGICAL" }, { "name": "Gene gun vaccine", "type": "DEVICE" }, { "name": "intramuscular vaccination", "type": "BIOLOGICAL" }, { "name": "intra-lesional vaccine administration", "type": "BIOLOGICAL" }, { "name": "therapeutic resection of the lesion", "type": "PROCEDURE" }, { "name": "imiquimod", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DEVICE", "PROCEDURE", "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 132, "start_date": "2009-09", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2018-07-09", "last_synced_at": "2026-10-14T16:05:38.561Z", "location_count": 3, "location_summary": "Birmingham, Alabama • Baltimore, Maryland", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00988559" }, { "nct_id": "NCT02678520", "title": "Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "3-D Conformal Radiation Therapy", "type": "RADIATION" }, { "name": "Intensity Modulated Radiation Therapy", "type": "RADIATION" }, { "name": "Casodex, Zoladex , Lupron", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "DRUG" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 0, "start_date": "2015-12", "completion_date": "2016-02", "has_results": false, "last_update_posted_date": "2016-07-22", "last_synced_at": "2026-10-14T16:05:38.561Z", "location_count": 1, "location_summary": "Fairway, Kansas", "locations": [ { "city": "Fairway", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02678520" }, { "nct_id": "NCT00111605", "title": "Study of an HIV Preventive Vaccine Given With or Without an Adjuvant in HIV Uninfected Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "HIV-1 gag DNA", "type": "BIOLOGICAL" }, { "name": "HIV-1 gag DNA plus IL-12 DNA adjuvant", "type": "BIOLOGICAL" }, { "name": "CTL MEP/RC529-SE/GM-CSF (CTL MEP vaccine)", "type": "BIOLOGICAL" }, { "name": "Sodium chloride injection (0.9%)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 144, "start_date": null, "completion_date": "2008-05", "has_results": false, "last_update_posted_date": "2021-10-14", "last_synced_at": "2026-10-14T16:05:38.561Z", "location_count": 3, "location_summary": "Birmingham, Alabama • Baltimore, Maryland • Nashville, Tennessee", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00111605" }, { "nct_id": "NCT00369291", "title": "CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Germ Cell Tumor", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm" ], "interventions": [ { "name": "keyhole limpet hemocyanin", "type": "BIOLOGICAL" }, { "name": "tetanus toxoid", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2003-09", "completion_date": "2010-05", "has_results": false, "last_update_posted_date": "2017-11-29", "last_synced_at": "2026-10-14T16:05:38.561Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00369291" }, { "nct_id": "NCT07300475", "title": "Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Triple Negative Breast Cancer" ], "interventions": [ { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Personalized cancer vaccine (PCV)", "type": "BIOLOGICAL" }, { "name": "AB248", "type": "DRUG" }, { "name": "pVAC tools neoantigen prediction algorithm", "type": "OTHER" }, { "name": "poly-ICLC", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2026-10-01", "completion_date": "2035-06-30", "has_results": false, "last_update_posted_date": "2026-09-04", "last_synced_at": "2026-10-14T16:05:38.561Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT07300475" }, { "nct_id": "NCT00871117", "title": "Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tetanus", "Acellular Pertussis", "Diphtheria" ], "interventions": [ { "name": "GSK Biologicals'Kinrix®", "type": "BIOLOGICAL" }, { "name": "Merck and Company's MMRII", "type": "BIOLOGICAL" }, { "name": "Merck and Company's Varivax", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "4 Years to 6 Years" }, "enrollment_count": 478, "start_date": "2009-03-31", "completion_date": "2010-06-15", "has_results": true, "last_update_posted_date": "2018-08-22", "last_synced_at": "2026-10-14T16:05:38.561Z", "location_count": 11, "location_summary": "Antioch, California • Daly City, California • Hayward, California + 7 more", "locations": [ { "city": "Antioch", "state": "California" }, { "city": "Daly City", "state": "California" }, { "city": "Hayward", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Roseville", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00871117" }, { "nct_id": "NCT01423825", "title": "Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Sub C gp140 Vaccine", "type": "BIOLOGICAL" }, { "name": "MF59C.1 Adjuvant", "type": "BIOLOGICAL" }, { "name": "Sodium chloride", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 27, "start_date": "2011-08", "completion_date": "2013-07", "has_results": false, "last_update_posted_date": "2021-10-14", "last_synced_at": "2026-10-14T16:05:38.561Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01423825" }, { "nct_id": "NCT02074150", "title": "ASIS for Botox in Upper Limb Spasticity", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Upper Limb Spasticity Unilaterally in Adults With History of Stroke", "Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors." ], "interventions": [ { "name": "Gadolinium", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 6", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 12,", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 18", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 24", "type": "DRUG" }, { "name": "Efficacy of Botox intramuscularly at Week 30", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 6", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 12", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 18", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 24", "type": "DRUG" }, { "name": "Efficacy of Botox subdermally at Week 30", "type": "DRUG" }, { "name": "Adverse Reactions of Botox intramuscularly", "type": "DRUG" }, { "name": "Adverse Reactions of Botox subdermally", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "li nguyen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 60, "start_date": "2016-01", "completion_date": "2017-06", "has_results": false, "last_update_posted_date": "2015-06-24", "last_synced_at": "2026-10-14T16:05:38.561Z", "location_count": 1, "location_summary": "Westminster, California", "locations": [ { "city": "Westminster", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02074150" }, { "nct_id": "NCT00295763", "title": "A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Differentiated Thyroid Cancer" ], "interventions": [ { "name": "Thyrogen (thyrotropin alfa for injection)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genzyme, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 61, "start_date": "2006-05", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2015-03-18", "last_synced_at": "2026-10-14T16:05:38.561Z", "location_count": 4, "location_summary": "Aurora, Colorado • Baltimore, Maryland • Columbus, Ohio + 1 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00295763" }, { "nct_id": "NCT00510874", "title": "Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Pumarix™", "type": "BIOLOGICAL" }, { "name": "Pandemrix ™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 780, "start_date": "2007-07-28", "completion_date": "2008-10-24", "has_results": true, "last_update_posted_date": "2018-08-17", "last_synced_at": "2026-10-14T16:05:38.561Z", "location_count": 7, "location_summary": "Huntsville, Alabama • Anaheim, California • Miami, Florida + 4 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Stockbridge", "state": "Georgia" }, { "city": "Lenexa", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00510874" } ] }